Page last updated: 2024-09-22

cyclopenta(c,d)pyrene

Description

cyclopenta(c,d)pyrene: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID33743
CHEMBL ID350278
CHEBI ID82279
MeSH IDM0066265

Synonyms (26)

Synonym
27208-37-3
cyclopenta[cd]pyrene
acepyrene
cyclopenta(cd)pyrene
acepyrylene
brn 2047004
cyclopenta(c,d)pyrene
cyclopenteno(c,d)pyrene
ccris 6930
chebi:82279 ,
CHEMBL350278
C19173
29xd62tn4d ,
unii-29xd62tn4d
FT-0638680
cyclopenta(cd)pyrnene
cyclopenta(cd)pyrene [iarc]
BZCXQYVNASLLQO-UHFFFAOYSA-N
DTXSID7074822
cyclopenta[cd]pyrene; acepyrene; acepyrylene; cyclopenta[c,d]pyrene
cyclopenta[c,d]pyrene 10 microg/ml in cyclohexane
cyclopenta[c,d]pyrene 10 microg/ml in acetonitrile
J-016691
Q27155853
pentacyclo[12.3.1.04,17.07,16.010,15]octadeca-1(18),2,4(17),5,7(16),8,10(15),11,13-nonaene
pentacyclo[12.3.1.0?,??.0?,??.0??,??]octadeca-1(18),2,4(17),5,7(16),8,10(15),11,13-nonaene

Drug Classes (1)

ClassDescription
pyrenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID160321Competition for [3H]benzo[a]pyrene-binding site of polycyclic aromatic hydrocarbon binding protein (PBP) from mouse liver1990Journal of medicinal chemistry, Feb, Volume: 33, Issue:2
Voronoi binding site model of a polycyclic aromatic hydrocarbon binding protein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (42.86)18.7374
1990's7 (25.00)18.2507
2000's6 (21.43)29.6817
2010's3 (10.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Dosage (4)

ArticleYear
DNA adducts of the ubiquitous environmental contaminant cyclopenta[cd]pyrene.
Carcinogenesis, Volume: 15, Issue: 5
1994
Carcinogenicity of the environmental pollutants cyclopenteno-[cd]pyrene and cyclopentano[cd]pyrene in mouse skin.
Carcinogenesis, Volume: 2, Issue: 4
1981
Dose-response relationships of the tumorigenicity of cyclopenta[cd]pyrene, benzo[a]pyrene and 6-nitrochrysene in a newborn mouse lung adenoma bioassay.
Carcinogenesis, Volume: 9, Issue: 5
1988
The analysis of the joint effect of substances on reversion systems and the assessment of antimutagenicity.
Mutation research, Volume: 267, Issue: 2
1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]